This product is suitable for qualitative detection of CYP2C19 gene polymorphism in human whole blood samples in vitro, including CYP2C19*2, CYP2C19*3 and CYP2C19*17.
Successfully obtained in the EU CE access certification.
Main clinical applications:
1.Guide clopidogrel rational use of drugs
2.Guide voriconazole rational use of drugs
3.Guide the rational use of proton pump inhibitors
4.Guide the rational use of antidepressants
Applicable Instruments:
HONGSHI SLAN-96, ABI 7500, and other four-channel fluorescence PCR instruments.
1. Full range of detection sites
Detection site coverage *2/*3/*17
2.High sensitivity
Unique nucleic acid invasion signal amplification technology, the lowest detection limit of 0.5 ng/ul.
3.Wide detection range
0.5 ng/ul-100 ng/ul
4.Lyophilized reagent
Good stability, no need for cold chain transportation, cost savings
5.Convenient operation
Full premixed reagents, ready to use, no need to dispense liquid
6.Automated result interpretation
Adopt customized software algorithm, the results are automatically read.